Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_006164.5(NFE2L2):c.127C>T(p.Arg43Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000898 in 1,613,922 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R43Q) has been classified as Benign.
NFE2L2 (HGNC:7782): (NFE2 like bZIP transcription factor 2) This gene encodes a transcription factor which is a member of a small family of basic leucine zipper (bZIP) proteins. The encoded transcription factor regulates genes which contain antioxidant response elements (ARE) in their promoters; many of these genes encode proteins involved in response to injury and inflammation which includes the production of free radicals. Multiple transcript variants encoding different isoforms have been characterized for this gene. [provided by RefSeq, Sep 2015]
NFE2L2 Gene-Disease associations (from GenCC):
immunodeficiency, developmental delay, and hypohomocysteinemia
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.09823206).
BP6
Variant 2-177234190-G-A is Benign according to our data. Variant chr2-177234190-G-A is described in ClinVar as [Benign]. Clinvar id is 134898.Status of the report is criteria_provided_single_submitter, 1 stars.